Corteva (CTVA)
(Delayed Data from NYSE)
$58.95 USD
0.00 (0.00%)
Updated Oct 17, 2024 04:02 PM ET
After-Market: $58.95 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth D Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$58.95 USD
0.00 (0.00%)
Updated Oct 17, 2024 04:02 PM ET
After-Market: $58.95 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth D Momentum B VGM
Zacks News
Should iShares Russell MidCap Value ETF (IWS) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for IWS
Corteva, Inc. (CTVA) Upgraded to Strong Buy: Here's Why
by Zacks Equity Research
Corteva, Inc. (CTVA) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Post Holdings (POST) Queued for Q3 Earnings: Things to Note
by Zacks Equity Research
Post Holdings' (POST) Q3 performance is likely to reflect adverse impacts from higher raw material, freight and manufacturing costs. Also, supply chain disruptions might be a concern.
Is Molson Coors (TAP) Slated to Report Earnings Beat in Q2?
by Zacks Equity Research
Molson Coors' (TAP) Q2 results are expected to reflect gains from innovation and premiumization efforts, aiding the top line. Elevated marketing and supply-chain costs are likely to have ailed.
Medifast (MED) Readies for Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Medifast's (MED) second-quarter 2022 results are likely to reflect gains from its OPTAVIA lifestyle solution and coaching support system, while escalated costs might have been a concern.
What's in Store for Service Corporation (SCI) in Q2 Earnings?
by Zacks Equity Research
Service Corporation's (SCI) second-quarter 2022 results are likely to reflect higher funeral revenues, whereas elevated costs might have been a deterrent.
Factors Likely to Decide Carter's (CRI) Fate in Q2 Earnings
by Zacks Equity Research
Carter's (CRI) second-quarter results are likely to reflect the impacts of weak retail sales, high freight costs and supply chain issues. However, online strength and improved price realization act as upsides.
Corteva, Inc. (CTVA) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Corteva, Inc. (CTVA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Church & Dwight (CHD) Queued for Q2 Earnings: Things to Note
by Zacks Equity Research
Church & Dwight's (CHD) second-quarter performance will likely reflect gains from solid brands and buyouts. However, rising inflation might have been a headwind.
Factors Likely to Decide Newell's (NWL) Fate in Q2 Earnings
by Zacks Equity Research
Higher costs, inflationary pressure and supply-chain woes are likely to have hurt Newell's (NWL) Q2 performance. Online strength, strong demand and core sales growth are likely to have aided.
Factors to Influence Procter & Gamble (PG) in Q4 Earnings
by Zacks Equity Research
Procter & Gamble's (PG) Q4 results are expected to reflect gains from strong demand for cleaning products and improved productivity, amid rising input costs and supply- chain woes.
Factors to Decide the Fate of Colgate (CL) in Q2 Earnings
by Zacks Equity Research
Colgate's (CL) Q2 results are expected to reflect gains from strong consumer demand, innovation, premiumization, digital growth and robust pricing actions amid rising raw material and logistic costs.
Here's How FEMSA (FMX) is Poised Just Ahead of Q2 Earnings
by Zacks Equity Research
FEMSA's (FMX) Q2 results are expected to reflect gains from strength across businesses, owing to effective growth strategies and robust demand across markets amid supply-chain and inflation woes.
Zacks.com featured highlights LPL Financial, Dollar Tree, Lamb Weston, M&T Bank and Corteva
by Zacks Equity Research
LPL Financial, Dollar Tree, Lamb Weston, M&T Bank and Corteva have been highlighted in this Screen of The Week article.
Corteva, Inc. (CTVA) Stock Moves -0.02%: What You Should Know
by Zacks Equity Research
In the latest trading session, Corteva, Inc. (CTVA) closed at $55.46, marking a -0.02% move from the previous day.
Hershey (HSY) Queues Up for Q2 Earnings: What to Expect?
by Zacks Equity Research
Hershey's (HSY) second-quarter 2022 results are likely to reflect gains from pricing and acquisitions, whereas elevated costs are likely to have been a concern.
Altria Group (MO) Readies for Q2 Earnings: What to Expect?
by Zacks Equity Research
Altria Group's (MO) second-quarter 2022 results are likely to reflect gains from pricing and strength in oral tobacco products, whereas elevated costs are likely to have been a concern.
Top 5 Low-Beta Stocks to Stay Safe From Near-Term Volatility
by Nalak Das
We have narrowed our search to five low-beta stocks. These are: LPLA, DLTR, MTB, LW and CTVA.
What's in the Offing for Pilgrim's Pride (PPC) in Q2 Earnings?
by Zacks Equity Research
Pilgrim's Pride's (PPC) Q2 performance is likely to reflect the growing Mexico business. Strength in U.S. business owing to foodservice and retail demand might have also been a tailwind.
Things You Need to Know Before Keurig's (KDP) Q2 Earnings
by Zacks Equity Research
Keurig's (KDP) Q2 results are likely to reflect solid demand, and in-market performance across categories and brands. Inflationary costs and supply-chain woes are likely to have hurt.
Kraft Heinz (KHC) Readies for Q2 Earnings: What to Expect?
by Zacks Equity Research
Kraft Heinz's (KHC) second-quarter 2022 results are likely to reflect rising cost concerns, whereas robust pricing is likely to have aided the company.
Things to Note as Lamb Weston (LW) Lines Up for Q4 Earnings
by Zacks Equity Research
Lamb Weston's (LW0 fourth-quarter fiscal 2022 results are likely to reflect gains from pricing and recovering foodservice demand amid rising cost concerns.
Here's Why Archer Daniels (ADM) is Poised for Q2 Earnings Beat
by Zacks Equity Research
Despite supply-chain issues and inflation, Archer Daniels' (ADM) Q2 results are likely to reflect gains from solid demand, a strong Nutrition segment and efforts to expand its solutions portfolio.
Things to Note as Kimberly-Clark (KMB) Lines Up for Q2 Earnings
by Zacks Equity Research
Kimberly-Clark's (KMB) second-quarter 2022 results are likely to reflect elevated input costs, while pricing and saving efforts are likely to have aided the company.
Things to Note as Mondelez (MDLZ) Lines Up for Q2 Earnings
by Zacks Equity Research
Mondelez International's (MDLZ) second-quarter 2022 results are likely to reflect elevated costs and supply-chain headwinds, while pricing and emerging market strength are likely to haveshould aided the company.